Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body ..read more

The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for treating the most common type of advanced breast cancer ..read more

Scientists have discovered a genetic aberration found in some prostate cancers that could allow more men to be successfully treated with targeted drug olaparib ..read more

Merck Serono, The Institute of Cancer Research (ICR), and the Wellcome Trust, London, today announced a co-development and license agreement building on two independent research programs at both the ICR and Merck Serono to identify inhibitors of tankyrase, an enzyme of the poly (ADP-ribose) polymerase family ..read more

Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis ..read more

Researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing several types of cancer. This could lead to improved early detection and targeted treatment across diverse populations ..read more

Cancer’s resistance to chemotherapy could be reversed by targeting lactate – the product that builds up as cancer cells convert nutrients to energy – according to new research ..read more

North Wales joins millions of participants worldwide for Terry Fox Run on 13 October. The Terry Fox Run UK raises funds for The Institute of Cancer Research, London. Wrexham, with the support of Ryan Reynolds, will become the first place in Wales to host a Terry Fox Run to honour Canadian hero Terry Fox ..read more

After first deciding to block earlier use of prostate cancer drug abiraterone, NICE has now suspended its appraisal, allowing more discussion on the price. Here Dr Eva Sharpe summarises what is new ..read more

Scientists have added to the list of inherited genetic mutations known to increase the risk of more aggressive prostate cancer ..read more